• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, August 7, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

Electromagnetic stimulation may improve arm and hand function after spinal cord injury

Bioengineer by Bioengineer
January 14, 2021
in Science News
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

BrainQ Technologies awards funding to Drs. Androwis and Kirshblum for pilot study of BQ therapy at Kessler Foundation for restoring arm and hand function in individuals with traumatic spinal cord injury

IMAGE

Credit: BrainQ Technologies

East Hanover, NJ. January 14, 2021. Ghaith Androwis, PhD, and Steven Kirshblum, MD, received a grant from BrainQ Technologies to study a potential treatment for arm and hand dysfunction in individuals with chronic spinal cord injury. The study is titled, “The safety and effectiveness of the use of a brain-computer interface-based electromagnetic field treatment in the management of patients with chronic spinal cord injury: A pilot study.”

Dr. Androwis is a research scientist in the Center for Mobility and Rehabilitation Engineering Research at Kessler Foundation. Dr. Kirshblum is senior medical officer and director of the Spinal Cord Injury Program for Kessler Institute for Rehabilitation, chief academic officer for the Select Medical Rehabilitation Division and the chief medical officer of Kessler Foundation. He serves as chair of the Department of Physical Medicine and Rehabilitation at Rutgers New Jersey Medical School.

An estimated 17,500 cases of new spinal cord injuries occur each year in the United States. More than half of these individuals experience loss of motor function of the upper extremities that limits their independence and adversely affects their quality of life. “”At Kessler Foundation, we look at how state-of-the-art technologies and novel interventions can improve motor control and function for persons with neurological disability,” said Dr. Kirshblum. “To achieve the best outcomes after spinal cord injury, restoring arm and hand function must be a priority in rehabilitative care,” he emphasized. “This study is an important first step toward increasing the ability of individuals to function more independently at home, in their communities, and the workplace,” he emphasized.

With this multi-center grant, researchers will test the safety and efficacy of noninvasive low frequency electromagnetic field stimulation delivered via the BQ System. Individuals with spinal cord injury (duration 18-30 months) will participate in the 34-week study. Functional status will be measured at baseline and compared with status following the experimental treatment. By quantifying gains in motor function, motor control and activities of daily living, this pilot study will provide preliminary information on the potential application of BrainQ’s therapy in rehabilitation programs for individuals with disability.

“We are very interested in testing the effectiveness of this novel and non-invasive approach in persons with spinal cord injury,” added Dr. Androwis. “Such interventions may improve participants’ performance of activities of daily living leading to gains in their overall quality of life. This particularly is important when an intervention can be provided simultaneously with conventional therapy.”

###

This multi-site study is being conducted at Kessler Foundation; The Miami Project to Cure Paralysis, Miami, FL (PI: Dr. Dalton Dietrich); and Sheba Medical Center, Israel (PI: Prof. Gabi Zeilig).

Learn about ongoing clinical studies at Kessler Foundation:

Contact our recruitment specialist at [email protected]

About BrainQ Technologies

BrainQ is an Israel-based startup developing a novel precision medicine therapy to reduce disability following neurodisorders such as spinal cord injury or stroke. The company is conducting clinical trials in top medical centers worldwide and has secured patents in all major global markets. BrainQ’s team and advisory board include a unique, multidisciplinary group with a vast background in data science and machine learning, neurology and neuroscience.

For more information: http://brainqtech.com/.

About Kessler Foundation

Kessler Foundation, a major nonprofit organization in the field of disability, is a global leader in rehabilitation research that seeks to improve cognition, mobility, and long-term outcomes–including employment–for people with neurological disabilities caused by diseases and injuries of the brain and spinal cord. Kessler Foundation leads the nation in funding innovative programs that expand employment opportunities for people with disabilities.

For more information on Kessler Foundation’s research, visit KesslerFoundation.org.

Facebook |http://www.facebook.com/KesslerFoundation

Twitter | http://twitter.com/KesslerFdn

Instagram | https://www.instagram.com/kesslerfdn

YouTube | http://www.youtube.com/user/KesslerFoundation

iTunes & SoundCloud | http://soundcloud.com/kesslerfoundation

Contacts:

Carolann Murphy, PA; 973.324.8382; [email protected]

Media Contact
Carolann Murphy, PA
[email protected]

Tags: Biomedical/Environmental/Chemical EngineeringBiotechnologyClinical TrialsDisabled PersonsGrants/FundingHealth CareRehabilitation/Prosthetics/Plastic SurgeryRobotry/Artificial IntelligenceTechnology/Engineering/Computer ScienceTrauma/Injury
Share12Tweet8Share2ShareShareShare2

Related Posts

Fighting Childhood Cancer Through Exercise Intervention

Fighting Childhood Cancer Through Exercise Intervention

August 7, 2025
blank

Allogeneic Microglia Transplants Restore Brain Therapy

August 7, 2025

Inhaled Peptide YKYY017 Shows Promise in Mild COVID-19

August 7, 2025

Microbial Diversity Boosts Active Compounds in Salvia Miltiorrhiza

August 7, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Neuropsychiatric Risks Linked to COVID-19 Revealed

    76 shares
    Share 30 Tweet 19
  • Overlooked Dangers: Debunking Common Myths About Skin Cancer Risk in the U.S.

    61 shares
    Share 24 Tweet 15
  • Predicting Colorectal Cancer Using Lifestyle Factors

    46 shares
    Share 18 Tweet 12
  • Modified DASH Diet Reduces Blood Sugar Levels in Adults with Type 2 Diabetes, Clinical Trial Finds

    45 shares
    Share 18 Tweet 11

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Fighting Childhood Cancer Through Exercise Intervention

Allogeneic Microglia Transplants Restore Brain Therapy

Inhaled Peptide YKYY017 Shows Promise in Mild COVID-19

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.